The role of horizontal gene transfer in the spread of trimethoprim-sulfamethoxazole resistance among uropathogenic Escherichia coli in Europe and Canada

被引:133
作者
Blahna, MT
Zalewski, CA
Reuer, J
Kahlmeter, G
Foxman, B
Marrs, CF
机构
[1] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA
[2] Cent Hosp Vaxjo, Dept Clin Microbiol, SE-35185 Vaxjo, Sweden
基金
美国国家卫生研究院;
关键词
urinary tract infections; epidemiology; antimicrobial resistance; integrons; E; coli;
D O I
10.1093/jac/dkl020
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: To describe the distribution of trimethoprim-sulfamethoxazole resistance genes and the role of horizontal gene transfer and clonal expansion in recent increases of antibiotic resistance rates among uropathogenic Escherichia coli in Europe and Canada. Methods: We identified antibiotic resistance alleles sul1, sul2, sul3 and dfr along with type 1 and type 2 integrons among 350 uropathogenic E. coli isolates from a cross-sectional study of acute, uncomplicated, community-acquired urinary tract infections in 16 western European countries and Canada (ECO.SENS). Results: Trimethoprim resistance gene distributions showed no regional dependency (P = 0.84). The most common trimethoprim resistance gene was dfrA1, which occurred in 37.9% of dfr containing isolates. Similarly, the sulfamethoxazole resistance gene distributions did not vary significantly by region (P = 0.20). sul2, the most common sulfamethoxazole resistance gene, was found in 77.9% of sulfamethoxazole-resistant isolates. The distribution of type 1 and type 2 integrons varied slightly by region (P = 0.04) with type 1 integrons being the more common (85.9%). We observed 34 combinations of the sul genes, dfr genes and integron types; the most common combinations were broadly disseminated across every region examined. Conclusions: Horizontal gene transfer plays a larger role than clonal expansion in the increase of trimethoprim-sulfamethoxazole resistance levels in Europe and Canada.
引用
收藏
页码:666 / 672
页数:7
相关论文
共 26 条
[1]   Integrons and gene cassettes: a genetic construction kit for bacteria [J].
Bennett, PM .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 43 (01) :1-4
[2]   A UK Multicentre study of the antimicrobial susceptibility of bacterial pathogens causing urinary tract infection [J].
Farrell, DJ ;
Morrissey, I ;
De Rubeis, D ;
Robbins, M ;
Felmingham, D .
JOURNAL OF INFECTION, 2003, 46 (02) :94-100
[3]   Sulphonamide resistance gene sul3 found in Escherichia coli isolates from human sources [J].
Grape, M ;
Sundström, L ;
Kronvall, G .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 52 (06) :1022-1024
[4]   Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections [J].
Gupta, K ;
Hooton, TM ;
Stamm, WE .
ANNALS OF INTERNAL MEDICINE, 2001, 135 (01) :41-50
[5]   ANALYSIS OF GENETIC LOCALIZATION OF THE TYPE-I TRIMETHOPRIM RESISTANCE GENE FROM ESCHERICHIA-COLI ISOLATED IN FINLAND [J].
HEIKKILA, E ;
SUNDSTROM, L ;
SKURNIK, M ;
HUOVINEN, P .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (08) :1562-1569
[6]   Acute uncomplicated cystitis in an era of increasing antibiotic resistance: A proposed approach to empirical therapy [J].
Hooton, TM ;
Besser, R ;
Foxman, B ;
Fritsche, TR ;
Nicolle, LE .
CLINICAL INFECTIOUS DISEASES, 2004, 39 (01) :75-80
[7]   TRIMETHOPRIM AND SULFONAMIDE RESISTANCE [J].
HUOVINEN, P ;
SUNDSTROM, L ;
SWEDBERG, G ;
SKOLD, O .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (02) :279-289
[8]   Acquired sulphonamide resistance genes in faecal Escherichia coli from healthy children in Bolivia and Peru [J].
Infante, B ;
Grape, M ;
Larsson, M ;
Kristiansson, C ;
Pallecchi, L ;
Rossolini, GM ;
Kronvall, G .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2005, 25 (04) :308-312
[9]  
Jones Louisa A, 2003, Commun Dis Intell Q Rep, V27 Suppl, pS103
[10]   The ECO•SENS Project:: a prospective, multinational, multicentre epidemiological survey of the prevalence and antimicrobial susceptibility of urinary tract pathogens -: interim report [J].
Kahlmeter, G .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 46 :15-22